Skip to main content

Table 4 Antibiotic resistance profile in 106 MDR isolates

From: Characterization of antimicrobial susceptibility, extended-spectrum β-lactamase genes and phylogenetic groups of Shigatoxin producing Escherichia coli isolated from patients with diarrhea in Iran

Antibiotic profile

No. of antibiotic groups

No. (%)

CTX/CAZ/CIP/LVX/Te/AM/SXT

5

19 (17.9)

CTX/CIP/LVX/Te/AM/SXT

5

8 (7.6)

CTX/CAZ/CIP/LVX/AM/SXT

4

2 (1.9)

CTX/ CAZ/CIP/LVX/Te/AM

4

1 (0.9)

CTX/CAZ/Te/AM/SXT

4

14 (13.2)

CTX/CIP/LVX/AM/SXT

4

2 (1.9)

CIP/LVX/Te/AM/SXT

4

4 (3.8)

CTX/Te/AM/SXT

4

12 (11.3)

CIP/Te/AN/SXT

4

1 (0.9)

CTX/CAZ/CIP/LVX/AM

3

1 (0.9)

CTX/CAZ/AM/SXT

3

6 (5.7)

CTX/CAZ/TZP/AM

3

1 (0.9)

CTX//CIP/LVX/AM

3

1 (0.9)

CIP/LVX/Te/SXT

3

1 (0.9)

CTX/Te/AM

3

4 (3.8)

CTX/AM/SXT

3

2 (1.9)

CIP/Te/AM

3

1 (0.9)

CIP/AM/SXT

3

1 (0.9)

LVX/Te/SXT

3

1 (0.9)

Te/AM/SXT

3

24 (22.7)

  1. AM ampicillin, AN amikacin, CAZ ceftazidime, CIP ciprofloxacin, CTX cefotaxime, LVX levofloxacin, STX trimethoprim + sulfamethoxazole, Te tetracyclines, TZP piperacillin + tazobactam, MDR multidrug resistant